VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $7,536,000 | +21.9% | 306,966 | 0.0% | 0.74% | +12.9% |
| Q2 2016 | $6,182,000 | -23.8% | 306,966 | -0.6% | 0.65% | -19.4% |
| Q1 2016 | $8,118,000 | -93.0% | 308,666 | -72.8% | 0.81% | -90.6% |
| Q4 2015 | $115,530,000 | -53.0% | 1,136,554 | -17.5% | 8.56% | -36.6% |
| Q3 2015 | $245,827,000 | -18.7% | 1,378,108 | +1.3% | 13.50% | -12.2% |
| Q2 2015 | $302,291,000 | +69.5% | 1,360,752 | +51.5% | 15.37% | +39.2% |
| Q1 2015 | $178,356,000 | +40.0% | 897,976 | +0.8% | 11.04% | +22.4% |
| Q4 2014 | $127,429,000 | -2.5% | 890,426 | 0.0% | 9.02% | -6.6% |
| Q3 2014 | $130,670,000 | +20.2% | 890,426 | +3.3% | 9.66% | +7.7% |
| Q2 2014 | $108,745,000 | +8.0% | 862,236 | +24.4% | 8.97% | +10.8% |
| Q1 2014 | $100,703,000 | +23.7% | 693,381 | 0.0% | 8.09% | +16.0% |
| Q4 2013 | $81,403,000 | +15.0% | 693,381 | +2.2% | 6.98% | -7.3% |
| Q3 2013 | $70,811,000 | +112.9% | 678,719 | +75.7% | 7.53% | +84.2% |
| Q2 2013 | $33,253,000 | – | 386,300 | – | 4.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |